Medtronic plc announced that its board of directors has approved a cash dividend for the second quarter of fiscal year 2026. The dividend, set at $0.71 per ordinary share, will be payable on October 17, 2025, to shareholders of record as of the close of business on September 26, 2025. This quarterly dividend aligns with the company’s previously announced increase in May 2025.
Medtronic has maintained a record of increasing its annual dividend payment for the past 48 consecutive years and is included in the S&P 500 Dividend Aristocrats index.
According to the company: “Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.”
The company notes that any forward-looking statements are subject to risks and uncertainties as described in its filings with the Securities and Exchange Commission.
For further information about Medtronic or investor details visit www.Medtronic.com or follow their LinkedIn page.
